In Response

Emil Peska¹, Mrinalini Balki^{2

3

4}, Wesla Pfeifer¹, Cynthia Maxwell⁵, Xiang Y Ye⁶, Kristi Downey¹, Jose C A Carvalho⁷

Affiliations

¹ Department of Anesthesiology and Pain Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
² Departments of Anesthesiology and Pain Medicine and Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
³ Department of Physiology, University of Toronto, Toronto, Ontario, Canada.
⁴ Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
⁵ Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
⁶ Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
⁷ Departments of Anesthesiology and Pain Medicine and Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada, jose.carvalho@sinaihealth.ca.

Emil Peska et al. Anesth Analg. 2024.

. 2024 May 1;138(5):e26-e27.

doi: 10.1213/ANE.0000000000006676. Epub 2024 Apr 15.

Emil Peska¹, Mrinalini Balki^{2

3

4}, Wesla Pfeifer¹, Cynthia Maxwell⁵, Xiang Y Ye⁶, Kristi Downey¹, Jose C A Carvalho⁷

¹ Department of Anesthesiology and Pain Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
² Departments of Anesthesiology and Pain Medicine and Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
³ Department of Physiology, University of Toronto, Toronto, Ontario, Canada.
⁴ Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
⁵ Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
⁶ Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
⁷ Departments of Anesthesiology and Pain Medicine and Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada, jose.carvalho@sinaihealth.ca.

No abstract available

References

1. Bamber JH, Lucas DN. Caveats for interpreting the results of up-down dose-finding studies for prophylactic oxytocin at caesarean delivery. Anesth Analg. 2024;138:e25.
1. Peska E, Balki M, Pfeifer W, et al. Oxytocin at elective cesarean delivery: a dose-finding study in pregnant people with twin pregnancy. Anesth Analg. 2024;138:814–820.
1. Heesen M, Carvalho B, Carvalho JCA, et al. International consensus statement on the use of uterotonic agents during caesarean section. Anaesthesia. 2019;74:1305–1319.
1. Butwick AJ, Coleman L, Cohen SE, Riley ET, Carvalho B. Minimum effective bolus dose of oxytocin during elective caesarean delivery. Br J Anaesth. 2010;104:338–343.
1. Carvalho JC, Balki M, Kingdom J, Windrim R. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol. 2004;104(5 Pt 1):1005–1010.